Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

Active, not recruitingOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

December 20, 2027

Study Completion Date

August 31, 2028

Conditions
Intracranial AneurysmsRuptured Aneurysm
Interventions
OTHER

Collection of blood sample in aneurysm

"In case of an endovascular treatment :~* A blood sample (venous or arterial) of 10 ml will be taken at the beginning of the procedure, an intra aneurysmal blood sample (1mL) will be taken during the procedure and a blood sample (arterial) of 1 mL will be taken at the end of the procedure.~* Iterative blood samples (arterial) of 10 mL will be taken at each follow up visit.~In case of a surgery treatment :~* A blood sample (venous or arterial) of 10 ml will be taken at the beginning of the surgery.~* A Tissue sample will be taken during the surgery~* Iterative blood samples (arterial) of 10 mL will be taken at each follow up visit."

Trial Locations (1)

75019

Fondation Ophtalmologique A. de Rothschild, Paris

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT03408379 - Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN | Biotech Hunter | Biotech Hunter